Financial report interval: 2025.12.30 - 2026.06.30
Overview: ILUVATAR COREX(09903) the Revenue is 1.091 B (--%), Beat estimate;the EBIT is -735.06 M (--%), Beat estimate;the EPS is 0.496 (--%), Beat estimate.